These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pathology and etiology of chronic rejection of the heart. Billingham ME Clin Transplant; 1994 Jun; 8(3 Pt 2):289-92. PubMed ID: 8061370 [TBL] [Abstract][Full Text] [Related]
4. Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Luckraz H; Goddard M; McNeil K; Atkinson C; Sharples LD; Wallwork J Ann Thorac Surg; 2006 Oct; 82(4):1212-8. PubMed ID: 16996910 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for the development of obliterative bronchiolitis after lung transplantation. Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205 [TBL] [Abstract][Full Text] [Related]
6. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Reichenspurner H; Girgis RE; Robbins RC; Yun KL; Nitschke M; Berry GJ; Morris RE; Theodore J; Reitz BA Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585 [TBL] [Abstract][Full Text] [Related]
7. [Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart-lung transplantation]. Sleiman C; Groussard O; Mal H; Fournier M Rev Mal Respir; 1996 Nov; 13(5 Suppl):S31-40. PubMed ID: 9011909 [TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of obliterative bronchiolitis in lung transplants]. Reynaud-Gaubert M Rev Mal Respir; 2003 Apr; 20(2 Pt 1):224-32. PubMed ID: 12844020 [TBL] [Abstract][Full Text] [Related]
9. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521 [TBL] [Abstract][Full Text] [Related]
17. Cardiac allograft vasculopathy: pathology, prevention and treatment. Kass M; Haddad H Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150 [TBL] [Abstract][Full Text] [Related]
18. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. Cooper JD; Billingham M; Egan T; Hertz MI; Higenbottam T; Lynch J; Mauer J; Paradis I; Patterson GA; Smith C J Heart Lung Transplant; 1993; 12(5):713-6. PubMed ID: 8241207 [TBL] [Abstract][Full Text] [Related]
19. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder? Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078 [TBL] [Abstract][Full Text] [Related]
20. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]